CAW
PRTK

Cornerstone Advisors (Washington)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2K Hold
433
– – ﹤0.01% 618
2020
Q2 		$2K Hold
433
– – ﹤0.01% 605
2020
Q1 		$1K Hold
433
– – ﹤0.01% 740
2019
Q4 		$2K Sell
433
-194
-31% -$673 ﹤0.01% 624
2019
Q3 		$3K Buy
+627
New +$2.51K ﹤0.01% 564

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cornerstone Advisors (Washington)'s PRTK Position: Q3 2020 in Review

Cornerstone Advisors (Washington) held its Paratek Pharmaceuticals, Inc. (PRTK) position steady in Q3 2020 at 433 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Cornerstone Advisors (Washington) first reported a position in PRTK in Q3 2019 and has held it in 5 quarters since. The position peaked at $3K in Q3 2019. 100 funds tracked by Wall St. Rank hold PRTK as of Q3 2020.

  • Cornerstone Advisors (Washington) held 433 shares of Paratek Pharmaceuticals, Inc. worth $2K as of Q3 2020.
  • Cornerstone Advisors (Washington) left its Paratek Pharmaceuticals, Inc. share count unchanged in Q3 2020.
  • Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #618 holding.
  • Cornerstone Advisors (Washington) first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2019 and has held it in 5 quarters since.
  • Cornerstone Advisors (Washington)'s Paratek Pharmaceuticals, Inc. position peaked at $3K in Q3 2019.
  • 100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.